7 High-Growth S&P 500 Stocks to Buy Now

01:52pm, Thursday, 12'th Oct 2023
While publicly traded securities that benefit from significant upside potential usually carry a higher-risk profile, with high-growth S&P 500 stocks, you can almost get the best of both worlds. To be
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-pois
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
With the current sector-wide downturn, it's not surprising that several large healthcare stocks are currently undervalued, relative to their intrinsic value, based on their fundamentals, cash flows, a
Investors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets.
Zimmer Biomet (ZBH) plans to work on the overall shift of the company's legacy knee systems to a fully rounded-out Persona portfolio.
Zimmer Biomet Holdings outlined strategies to gain market share in the knee sector and foster innovation in hip products. ZBH has raised its 2023 growth forecast, reflecting confidence in its strategi
Zimmer Biomet (ZBH) is benefiting from increased provider capacity, resulting in backlog pull-through in the recent quarters.
Investors are optimistic about Zimmer Biomet (ZBH) due to innovative new product launches and solid execution.
The "Halftime Report" traders give their top picks to watch for the second half.
Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.
Zimmer Biomet Holdings, Inc. has experienced a selloff alongside the healthcare sector in H2 FY'23. Despite the recent downturn, the company still represents compelling long-term value in my view. The
Health Care sector ETF (XLV) has underperformed the S&P 500 by 15 percentage points but has shown a modest revival in the last month. Zimmer Biomet had a solid earnings report and raised its 2023 reve
Barring S.E.T., Zimmer Biomet (ZBH) records strong growth across each of its business segments in the second quarter.
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE